Three Researchers Granted Over $1 Million to De-Risk and Progress Preclinical Drug Candidates for Neurodegenerative Diseases
· newswise.com · popularity 18/100 · 0 similar stories today · Philanthropy & Nonprofits (Society, Rights & Work)
Read the original at newswise.com →
Summary
The Rainwater Charitable Foundation (RCF), one of the largest independent funders of neurodegenerative research, today announced over $1 million in grants to fund three innovative one-year research projects focused on targeting tau as an underlying disease driver, stemming from the 2026 Sprint to Lead (S2L) drug discovery grant program.
Found in: Newswise. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 11.